B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sb 202190

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sb 202190, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

sb
35 shared targets
doramapimod
23 shared targets
cep
13 shared targets
gefitinib
16 shared targets
erlotinib
18 shared targets
sb
6 shared targets
vandetanib
18 shared targets
canertinib
18 shared targets
Afatinib
13 shared targets · score 50.1
linifanib
16 shared targets
Loading evidence profile...

This evidence profile for Sb 202190 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.